(NYSE MKT:CMCL),(LSE – AIM:CMCL),(LSE:CMCL.L),(LSE:CMCL.LN), ST HELIER, Jersey, Oct. 21, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (NYSE AMERICAN, AIM and VFEX: CMCL) (“Caledonia” or “the Company”) announces gold production from the Blanket Mine in Zimbabwe (“Blanket”) for the quarter ended September 30, 2025 (“Q3 2025” or the “Quarter”). All production numbers are expressed on […]
(Paris:STMPA),(NYSE:STM), Singapore's largest industrial district cooling system begins operationsto support STMicroelectronics' decarbonization strategy Designed, built, owned, and operated by a joint venture between SP Group and Daikin Airconditioning (Singapore), the innovative district cooling system will significantly improve the environmental performance of ST's high-volume semiconductor manufacturing site in Singapore New system expected to reduce carbon emissions
(LSE – AIM:AMRQ),(Iceland:AMRQ),(TSX-V:AMRQ),(OTC US:AMRQF),(OTCQX:AMRQF), Reykjavík, Oct. 21, 2025 (GLOBE NEWSWIRE) — Amaroq Ltd.(“Amaroq” or the “Company”) Notice to holders of Icelandic Depository Receipts Simplification and streamlining of Amaroq's securities under a single ISIN TORONTO, ONTARIO – 21 October 2025 – Amaroq Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ, OTCQX: AMRQF), announces that its Icelandic Depositary Receipts
(Euronext Amsterdam:INGA),(Brussels:INGA), Progress on share buyback programme ING announced today that, as part of our EUR2.0 billion share buyback programme announced on 2 May 2025, in total 4,381,000 shares were repurchased during the week of 13 October 2025 up to and including 17 October 2025. The shares were repurchased at an average price of EUR20.91
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO(R) (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response rate, sustained improvement in desmoid
Notice to holders of Icelandic Depository Receipts Simplification and streamlining of Amaroq's securities under a single ISIN GlobeNewswire October 21, 2025 Reykjavík, Oct. 21, 2025 (GLOBE NEWSWIRE) — Amaroq Ltd.(“Amaroq” or the “Company”) Notice to holders of Icelandic Depository Receipts Simplification and streamlining of Amaroq's securities under a single ISIN TORONTO, ONTARIO – 21 October
Singapore's largest industrial district cooling system begins operations to support STMicroelectronics' decarbonization strategy GlobeNewswire October 21, 2025 Singapore's largest industrial district cooling system begins operationsto support STMicroelectronics' decarbonization strategy Designed, built, owned, and operated by a joint venture between SP Group and Daikin Airconditioning (Singapore), the innovative district cooling system will significantly improve the environmental
Progress on share buyback programme GlobeNewswire October 21, 2025 Progress on share buyback programme ING announced today that, as part of our EUR2.0 billion share buyback programme announced on 2 May 2025, in total 4,381,000 shares were repurchased during the week of 13 October 2025 up to and including 17 October 2025. The shares were
PIVOT-PO Phase 3 Data Show Tebipenem HBr's Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs) GlobeNewswire October 21, 2025 Data presented at IDWeek 2025 after study stopped early for efficacy Primary endpoint met, demonstrating non-inferiority of oral tebipenem HBr compared to intravenous treatment1 Data will be shared with